Tuesday Night IBS

In this special crossover podcast episode, Tuesday Night IBS host Jeffrey Roberts, MSEd, BSc, and Kate Scarlata, MPH, RDN, are joined live by William Chey, MD, and Amanda Lynett, MS, RDN, at FOOD the Main Course Conference in Ann Arbor, MI.

Amanda Lynett MS, RDN, is a registered dietitian with her masters. Amanda is with the Division of Gastroenterology at Michigan Medical in Ann Arbor.

Jeffrey Roberts, MSEd, BSc, is a patient advocate and creator of the first website for IBS sufferers. He is the co-founder of Tuesday Night IBS.

Kate Scarlata, MPH, RDN, is a US-based dietitian with over 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance.

We’d love to hear from you! Send your comments/questions to [email protected]. Follow uson X @HealioGastro @sameerkberry @umfoodoc. For more Tuesday Night IBS, be sure check out TuesdayNightIBS.com and to follow and subscribe to their podcast.

Disclosures: Chey and Roberts report no relevant financial disclosures. Scarlata reports stock options with Epicured LLC and FODY Food Company, financial support from Dr. Schar, Mahana Therapeutics, Nestle Health Science, Olipop, Pendulum, QOL Medical.

On this special episode of Tuesday Night IBS, we talk with the co-principal investigator, Alex Ford, MD, from Leeds University in the UK, about the ATLANTIS trial of Amitriptyline for irritable bowel syndrome (IBS) in primary care, which was funded by the Health Technology Assessment program of the National Institute for Health and Care Research and the TRITON trial using Ondansetron to manage irritable bowel syndrome with diarrhea.

Dr. Alex Ford is a Professor and Honorary consultant gastroenterologist at St. James’s University Hospital, Leeds, UK. His main interest is in the epidemiology, diagnosis, and treatment of disorders of gut-brain interaction, such as irritable bowel syndrome and functional dyspepsia. He is an Associate Editor for Alimentary Pharmacology & Therapeutics. He has published over 450 peer-reviewed articles, including original scientific papers in The Lancet, JAMA, BMJ, Gastroenterology, Gut, Archives of Internal Medicine, and The American Journal of Gastroenterology.

On this special episode of Tuesday Night IBS, we talk with the co-principal investigator, Alex Ford, MD, from Leeds University in the UK, about the ATLANTIS trial of Amitriptyline for irritable bowel syndrome (IBS) in primary care, which was funded by the Health Technology Assessment program of the National Institute for Health and Care Research and the TRITON trial using Ondansetron to manage irritable bowel syndrome with diarrhea.

Dr. Alex Ford is a Professor and Honorary consultant gastroenterologist at St. James’s University Hospital, Leeds, UK. His main interest is in the epidemiology, diagnosis, and treatment of disorders of gut-brain interaction, such as irritable bowel syndrome and functional dyspepsia. He is an Associate Editor for Alimentary Pharmacology & Therapeutics. He has published over 450 peer-reviewed articles, including original scientific papers in The Lancet, JAMA, BMJ, Gastroenterology, Gut, Archives of Internal Medicine, and The American Journal of Gastroenterology.

Join us as experts Dr. Anthony Lembo and Dr. Lin Chang, discuss the future of IBS management with more precise testing and tailored treatments and the benefits of a new diagnostic test for IBS, InFoods IBS. 

Join an expert panel and a patient living with IBS-C as we deep dive into real-life patient cases, discuss evidence-based strategies to diagnose patients with IBS-C from a biopsychosocial approach, and use shared decision-making to help patients regain control of their lives and improve patient and provider satisfaction. Featuring Christina Hanson, FNP-C, Kimberly Kearns, APRN, ANP-BC, and Suzanne, a patient with IBS-C.

Jeffrey Roberts and Johannah Ruddy talk with registered GI dietitian Taylor Hanna from Diet vs. Disease about SIBO and how it differs from IBS but can occur concurrently. How common is it, how is it treated, and how can diet therapy help patients keep symptoms related to SIBO from returning? Don’t miss this special episode.

Join Tuesday Night IBS and our friends at Diet vs Disease as we feature Kate Scarlata, RD and William Chey, MD to discuss this important topic of SIBO and IBS. We will hear from both presenters about SIBO, what it is, how to treat and prevent it, and how good access to dietitians and other HCP can improve health outcomes.

Kate Scarlata RD, MPH, discusses how a multi-disciplinary approach to IBS management can benefit symptoms and improve quality of life.

 Dr. Megan E. Riehl, discusses IBS myths in symptoms and treatments, as well as IBS mimickers that need to be considered in the diagnostic process. 

Darren Brenner, MD outlines the testing recommendations when looking at an IBS diagnosis based on sub-type. #WorldIBSDay2023